@article{4ef799ce66234853b3e09e56a248147c,
title = "Direct-to-Patient Clinical Trials: One Small Step or a Giant Leap?",
abstract = "Genome driven precision oncology has transformed the landscape of multiple cancers. However, access barriers exist. A recent study exemplified a direct-to-patient outreach program via social media through the implementation of a global program that offered free tumor genomic testing with a focus on rare cancers.",
author = "Aakash Desai and Vivek Subbiah",
note = "Funding Information: V. Subbiah is an Andrew Sabin Family Foundation fellow at the University of Texas MD Anderson Cancer Center. V. Subbiah acknowledges the support of the Jacquelyn A. Brady Fund. V. Subbiah is supported by a US NIH grant (R01CA242845 Funding Information: V. Subbiah is an Andrew Sabin Family Foundation fellow at the University of Texas MD Anderson Cancer Center. V. Subbiah acknowledges the support of the Jacquelyn A. Brady Fund. V. Subbiah is supported by a US NIH grant (R01CA242845 and R01CA273168); MD Anderson Cancer Center Department of Investigational Cancer Therapeutics is supported by the Cancer Prevention and Research Institute of Texas (RP1100584), the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy (1U01 CA180964), NCATS (Center for Clinical and Translational Sciences) grant (UL1 TR000371), and the MD Anderson Cancer Center Support Grant (P30 CA016672). We also acknowledge the team at DrawImpacts for help in creating Figure 1. Publisher Copyright: 2023 American Association for Cancer Research.",
year = "2023",
month = jul,
day = "1",
doi = "10.1158/1078-0432.CCR-23-0746",
language = "English (US)",
volume = "29",
pages = "2339--2341",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "13",
}